Private Markets, Angel and Secondary Investing, Sacra

Sacra

Private Markets, Angel and Secondary Investing

Bringing transparency to private markets so investors, founders, and employees can build on conviction. Sacra delivers deeply researched insights on the private companies shaping tomorrow's markets. By surfacing the data, context, and operator perspective that are missing from private markets today, we help secondary buyers and sellers price equity accurately and unlock liquidity for the people building these businesses.

Private Capital Markets

<ul><li>Sacra estimates Kindbody hit $180M in revenue in 2023, growing approximately 50% year-over-year, driven by increasing demand for fertility services and employer benefits programs.</li><li>Kindbody's current $1.8B valuation reflects strong investor confidence in its vertically-integrated fertility care model.</li><li>Bloomberg reported in September 2025 that Kindbody faced a "financial crisis" and was "hemorrhaging cash" according to internal documents.</li></ul>

Sacra estimates Kindbody hit $180M in revenue in 2023, growing approximately 50% year-over-year, driven by increasing demand for fertility services and employer benefits programs.Kindbody's current $1.8B valuation reflects strong investor confidence in its vertically-integrated fertility care model.Bloomberg reported in September 2025 that Kindbody faced a "financial crisis" and was "hemorrhaging cash" according to internal documents.

<ul><li>Sacra estimates Maven will hit $268M in annual recurring revenue (ARR) by the end of 2024, growing 26% year-over-year.</li><li>Maven has successfully diversified beyond their original maternity focus, with pediatrics doubling to 3M covered lives in 2024 and menopause growing 300% year-over-year to 550 clients.</li><li>Maven Clinic is currently valued at $1.7 billion, with an estimated $268M in annual recurring revenue for 2024, representing a 6.9x forward revenue multiple.</li></ul>

Sacra estimates Maven will hit $268M in annual recurring revenue (ARR) by the end of 2024, growing 26% year-over-year.Maven has successfully diversified beyond their original maternity focus, with pediatrics doubling to 3M covered lives in 2024 and menopause growing 300% year-over-year to 550 clients.Maven Clinic is currently valued at $1.7 billion, with an estimated $268M in annual recurring revenue for 2024, representing a 6.9x forward revenue multiple.

<ul><li>Maven Clinic will hit $268M of ARR in 2024, up 26% YoY, with their women’s health benefit offering now covering 17 million people globally.</li><li>After doubling down on fertility, Maven has now won their biggest customer ever in Amazon, who switched away from incumbent Progyny (NASDAQ: PGNY) for 2025.</li><li>Maven's asset-light model combining coaching, content and telehealth has enabled them to go global (175 countries)—without sacrificing retention (98% customer retention).</li></ul>

Maven Clinic will hit $268M of ARR in 2024, up 26% YoY, with their women’s health benefit offering now covering 17 million people globally.After doubling down on fertility, Maven has now won their biggest customer ever in Amazon, who switched away from incumbent Progyny (NASDAQ: PGNY) for 2025.Maven's asset-light model combining coaching, content and telehealth has enabled them to go global (175 countries)—without sacrificing retention (98% customer retention).

<ul><li>Where we see Pawp evolving over the next few years is in really owning what we define as pet care—which not only encompasses vet care and the medical aspects of your pet&#39;s health, but also their overall wellbeing.</li><li>So far, we&#39;ve facilitated more than 100,000 consultations online in a year and a half, and deflected roughly $10 million worth of unnecessary vet visits.</li><li>We&#39;re leveraging partnerships to help distribute Pawp <em>en masse</em>—essentially providing pet parents everywhere access to affordable pet care.</li></ul>

Where we see Pawp evolving over the next few years is in really owning what we define as pet care—which not only encompasses vet care and the medical aspects of your pet&#39;s health, but also their overall wellbeing.So far, we&#39;ve facilitated more than 100,000 consultations online in a year and a half, and deflected roughly $10 million worth of unnecessary vet visits.We&#39;re leveraging partnerships to help distribute Pawp en masse—essentially providing pet parents everywhere access to affordable pet care.

Marc Atiyeh, CEO Of Pawp, On Building Telehealth For Pets

United States

Network of fertility clinics offering reproductive care and employer-sponsored family-building benefits

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Kindbody (KINDBODY US)

Primer: Kindbody - 10 Mar 2026

Network of fertility clinics offering reproductive care and employer-sponsored family-building benefits

Sacra

Primer: Maven Clinic - 20 Apr 2026

Telehealth benefit for employers offering fertility, maternity, pediatrics, and menopause care

Sacra

Maven Clinic At $268M ARR

TL;DR: Sacra estimates that Maven Clinic will hit $268M of ARR in 2024, up 26% YoY, with their women’s health benefit offering now covering 17...

Sacra

Marc Atiyeh, CEO Of Pawp, On Building Telehealth For Pets

Sacra interview with Marc Atiyeh, CEO and co-founder of Pawp.

Sacra

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)